Breakpoints cover image

#82 – ID Literature Year in Review (LIVE from MAD-ID)

Breakpoints

00:00

The ECMID Late Breakers

In this document, they actually suggest choosing a macrolide. And I think that's a pretty good suggestion because there's some observational data that suggests that giving combination therapy with amacrolide in these patients. The other thing that I would just comment on, they also talk about tamaflu, and they also suggest that in patients who have it. So I will encourage you to take a look at these documents in a little bit more detail,. But nice support for different recommendations for treating severe community acquired pneumonia.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
 Get the app